Mergers & Acquisitions - Pharmaceutical, Mergers & Acquisitions

Filter

Popular Filters

1 to 25 of 653 results

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

09-12-2014

The Indian Competition Commission has granted domestic generics company Sun Pharmaceutical Industries…

IndiaMergers & AcquisitionsPharmaceuticalRanbaxySun Pharmaceutical

Sources say Merck to buy Cubist in $7 billion deal

Sources say Merck to buy Cubist in $7 billion deal

08-12-2014

Sources close to the matter say pharma giant Merck & Co has entered negotiations with Cubist Pharmaceuticals…

CubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceuticalUSA

GlaxoSmithKline abandons plans to divest Established Products portfolio

05-12-2014

In what has come as something of a surprise, UK pharma major GlaxoSmithKline has abandoned its plan to…

EuropeGlaxoSmithKlineMergers & AcquisitionsNorth AmericaPharmaceutical

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

Otsuka acquires Avanir for $3.5 billion

Otsuka acquires Avanir for $3.5 billion

02-12-2014

The US subsidiary of Japanese drug maker Otsuka has acquired US CNS specialist Avanir Pharmaceuticals…

AvanirJapanMergers & AcquisitionsNeurologicalNuedextaOtsuka PharmaceuticalPharmaceuticalUSA

FTC puts conditions on GSK/Novartis consumer JV

27-11-2014

The US Federal Trade Commission has voted to approve UK pharma giant GlaxoSmithKline’s proposed acquisition…

Dr Reddy's LaboratoriesGlaxoSmithKlineHabitrolMergers & AcquisitionsNicodermNovartisPharmaceuticalRegulationUSAVaccines

Recipharm acquires Flamel Technologies facility in France

27-11-2014

Swedish pharmaceutical contract development and manufacturing organization Recipharm AB and French drug…

Flamel TechnologiesFranceMergers & AcquisitionsPharmaceuticalProductionRecipharm

Big pharma increasingly collaborating with Indian companies

Big pharma increasingly collaborating with Indian companies

26-11-2014

Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

Gilead SciencesIndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

Apellis Pharma to acquire former parent Potentia

Apellis Pharma to acquire former parent Potentia

26-11-2014

USA-based Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals,…

Apellis PharmaceuticalsMergers & AcquisitionsOphthalmicsPharmaceuticalPotentia PharmaceuticalsUSA

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

BioMarin to acquire Prosensa for up to $840 million

BioMarin to acquire Prosensa for up to $840 million

24-11-2014

US drugmaker BioMarin Pharmaceutical has entered into a definitive agreement to purchase all of the outstanding…

BioMarin PharmaceuticaldrisapersenMergers & AcquisitionsPharmaceuticalProsensaRare diseases

Valeant admits disappointment at loss of takeover target Allergan to Actavis

Valeant admits disappointment at loss of takeover target Allergan to Actavis

19-11-2014

Canadian drugmaker Valeant International has admitted that the loss of hostile takeover target Allergan…

ActavisAllerganCanadaMergers & AcquisitionsPharmaceuticalValeant

Ricerca Biosciences sells out to equity investment group

19-11-2014

After conducting a thorough process to evaluate strategic acquisition offers for the company, the Ricerca…

Mergers & AcquisitionsPharmaceuticalResearchRicerca Biosciences

Allergan agrees to $66 billion acquisition by Actavis

Allergan agrees to $66 billion acquisition by Actavis

17-11-2014

Confirming what were becoming ever stronger rumors over the weekend, Ireland-headquartered Actavis this…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Reckitt Benckiser outlines plans for demerger of the RB Pharma business

17-11-2014

Following the announcement made by UK-based consumer goods giant Reckitt Benckiser that it was pursuing…

FinancialIndiviorMergers & AcquisitionsPharmaceuticalReckitt BenckiserReckitt Benckiser Pharmaceuticals

Recipharm acquires Portuguese CDMO

14-11-2014

Swedish pharmaceutical contract development and manufacturing organization, Recipharm AB has acquired…

LusomedicamentaMergers & AcquisitionsPharmaceuticalProductionRecipharm

Fresenius Kabi dumps planned Russian joint venture

09-11-2014

Fresenius Kabi and its partners Sistema JSFC and Zenitco Finance Management have mutually agreed to terminate…

BinnopharmFinancialFreseniusFresenius KabiMergers & AcquisitionsPharmaceuticalProductionRussia

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

Perrigo expands in Europe with acquisition of Omega Pharma

06-11-2014

Health care company Perrigo has entered into a definitive agreement to acquire Belgium-based over-the-counter…

Mergers & AcquisitionsOmega PharmaPerrigoPharmaceutical

UPDATE: AstraZeneca divests Myalept for $325 million

06-11-2014

Anglo-Swedish pharma major AstraZeneca today announced that it has entered into a definitive agreement…

Aegerion PharmaceuticalsAstraZenecaMergers & AcquisitionsMyaleptPharmaceuticalRare diseases

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

04-11-2014

MedImmune, a US subsidiary of Anglo-Swedish pharma major AstraZeneca has entered into an agreement to…

AstraZenecaDefiniensMedImmuneMergers & AcquisitionsOncologyPharmaceutical

Zogenix acquires UK-based Brabant Pharma for up to $130 million

28-10-2014

US CNS focused drugmaker Zogenix says it has acquired Brabant Pharma, a privately-held UK-based pharmaceutical…

BrabafenBrabant PharmaMergers & AcquisitionsNeurologicalPharmaceuticalZogenix

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

1 to 25 of 653 results

Back to top